ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer

NCT00415779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: zoledronic acid

Sponsor

National Cancer Institute, Naples